Axon degeneration: context defines distinct pathways

MJ Geden, M Deshmukh - Current opinion in neurobiology, 2016 - Elsevier
MJ Geden, M Deshmukh
Current opinion in neurobiology, 2016Elsevier
Highlights•Axotomy, axon apoptosis, and axon pruning engage distinct pathways of
degeneration.•NMNATs and SARM1 are key mediators of axotomy-induced axon
degeneration.•Context of NGF deprivation defines axon degeneration during apoptosis vs
pruning.•Caspases are activated via distinct mechanisms during apoptosis vs pruning.Axon
degeneration is an essential part of development, plasticity, and injury response and has
been primarily studied in mammalian models in three contexts: 1) Axotomy-induced …
Highlights
  • Axotomy, axon apoptosis, and axon pruning engage distinct pathways of degeneration.
  • NMNATs and SARM1 are key mediators of axotomy-induced axon degeneration.
  • Context of NGF deprivation defines axon degeneration during apoptosis vs pruning.
  • Caspases are activated via distinct mechanisms during apoptosis vs pruning.
Axon degeneration is an essential part of development, plasticity, and injury response and has been primarily studied in mammalian models in three contexts: 1) Axotomy-induced Wallerian degeneration, 2) Apoptosis-induced axon degeneration (axon apoptosis), and 3) Axon pruning. These three contexts dictate engagement of distinct pathways for axon degeneration. Recent advances have identified the importance of SARM1, NMNATs, NAD+ depletion, and MAPK signaling in axotomy-induced Wallerian degeneration. Interestingly, apoptosis-induced axon degeneration and axon pruning have many shared mechanisms both in signaling (eg DLK, JNKs, GSK3α/β) and execution (eg Puma, Bax, caspase-9, caspase-3). However, the specific mechanisms by which caspases are activated during apoptosis versus pruning appear distinct, with apoptosis requiring Apaf-1 but not caspase-6 while pruning requires caspase-6 but not Apaf-1.
Elsevier